The global cell freezing media market size reached US$ 137.7 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 241.3 Million by 2028, exhibiting a growth rate (CAGR) of 9.5% during 2023-2028. The increasing advancements in biotechnology, rapid expansion of pharmaceutical research, rising prevalence of chronic diseases, growing technological advancements and the implementation of favorable government policies are some of the major factors propelling the market.
|Market Size in 2022
||US$ 137.7 Million
|Market Forecast in 2028
||US$ 241.3 Million
|Market Growth Rate (2023-2028)
Cell freezing media is a specialized solution designed to preserve cells' viability during cryopreservation, which involves freezing cells at extremely low temperatures. It consists of a basal medium, cryoprotective agents like dimethyl sulfoxide (DMSO) or glycerol, and often, additional nutrients and supplements. It is extensively used in research labs, biobanks, and pharmaceutical companies for preserving a variety of cell types, including stem cells, mammalian cells, and microbial cells. Cell freezing media allows for long-term storage and facilitates research that may require the revival of these cells later. It offers enhanced cell viability post-thaw and a higher rate of successful experimentation due to better-preserved cellular structures and functions.
The increasing advancements in biotechnology leading to a growing need for preserving various cell types for extended periods is one of the factors driving the market growth. In addition to this, the rising reliance on cellular research by the pharmaceutical sector for drug discovery and development, thus requiring high-quality cell freezing media, is creating a positive outlook for the market growth. Moreover, the increasing prevalence of chronic diseases necessitating more research, which in turn requires the storage of biological samples, is providing a thrust to the market growth. Additionally, the growing focus on stem cell research for therapeutic applications leading to an increased requirement for cell freezing media to store and transport these valuable cells is positively impacting the market growth. Furthermore, the increasing implementation of favorable governmental regulations that promote rigorous standards for cell preservation, encouraging the use of specialized cell freezing media, is also strengthening the market growth. In line with this, rapid technological innovations, such as the development of more efficient and safer types of cell freezing media that make the process more reliable and cost-effective are supporting the market growth.
Cell Freezing Media Market Trends/Drivers:
Rapid advancements in biotechnology
The rising advancements in biotechnology, particularly in the fields of genomics, proteomics, and cellular biology, are creating a positive outlook for the market growth. In line with this, the increasing need for precise and reliable methods for storing cells, tissues, and other biological samples is providing a thrust to the market growth. Cell freezing media ensures that cells remain viable and functional throughout the storage process, facilitating ongoing and future research. In addition to this, the growing demand for high-quality cell freezing media that meets the stringent requirements of modern cellular research is propelling the market growth. Moreover, the widespread product utilization in emerging technologies like clustered regularly interspaced short palindromic repeats (CRISPR) for gene editing and chimeric antigen receptor (CAR-T) therapies for cancer treatment is positively impacting the market growth. Furthermore, the rising need to preserve cells' structural and functional integrity for such sophisticated applications makes cell freezing media indispensable.
Expansion in pharmaceutical research
The increasing utilization of cell freezing media in drug discovery and development that involves a myriad of cellular tests and screenings is positively impacting the market growth. In line with this, the growing need to ensure the consistency and reliability of these experiments requiring cells to be stored and transported in a state that retains their viability is supporting the market growth. Moreover, the widespread product utilization as pharmaceutical companies often operate on a global scale, conducting multi-center trials that require the use of the same cellular materials across different laboratories is favoring the market growth. Moreover, the increasing demand for specialized types of cells freezing media as pharmaceutical companies delve into more personalized medicine and targeted therapies is providing a thrust to the market growth.
Increasing prevalence of chronic diseases
The increasing focus on medical research aimed at understanding chronic diseases, such as diabetes, cancer, and cardiovascular diseases, better and developing more effective treatments is creating a positive outlook for the market growth. Besides this, the growing utilization of cell freezing media that enable researchers to preserve disease-specific cells for extended periods, providing a robust resource for ongoing and future investigations, is providing a considerable boost to the market growth. This long-term preservation is particularly crucial for studying the progression of chronic diseases and the long-term effects of potential treatments. Moreover, the growing demand for high-quality cell freezing media, essential for ensuring that these cells retain their original characteristics over time, making it a critical component in the study and fight against chronic diseases, is positively impacting the market growth.
Cell Freezing Media Industry Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global cell freezing media market report, along with forecasts at the global, regional, and country levels for 2023-2028. Our report has categorized the market based on product, application, and end use.
Breakup by Product:
DMSO dominate the market
The report has provided a detailed breakup and analysis of the market based on the product. This includes DMSO, glycerol, and others. According to the report, DMSO represented the largest segment.
Dimethyl sulfoxide (DMSO) holds the largest cell freezing media market share. It is a polar aprotic solvent that serves as a cryoprotective agent, meaning it protects cells from the damaging effects of ice crystal formation during the freezing process. The increasing ability of DMSO to penetrate cellular membranes, effectively minimizing intracellular ice formation, thus preserving the cell's structural and functional integrity during cryopreservation, is creating a positive outlook for the market. Moreover, the widespread utilization of DMSO for a wide range of cell types, including mammalian cells, stem cells, and even microbial cells, is supporting the market growth. Besides this, the effectiveness of DMSO in ensuring high post-thaw cell viability, extensively documented in scientific literature, is favoring the market growth. Furthermore, DMSO offers a balance of high performance and affordability, making it accessible for research labs with budget constraints. Additionally, the compound's chemical stability allows it to be stored for extended periods without degradation, making it a practical option for long-term projects.
Breakup by Application:
- Stem Cell Lines
- Cancer Cell Lines
Stem cell lines dominate the market
The report has provided a detailed breakup and analysis of the market based on the application. This includes stem cell lines, cancer cell lines, and others. According to the report, stem cell lines represented the largest segment.
Stem cell lines represent the largest application segment in the cell freezing media market, as this prominence is rooted in the critical role that stem cells play in research and medical applications. In line with this, stem cells are unique in their ability to differentiate into specialized cell types, making them invaluable for various applications, including tissue engineering, regenerative medicine, and drug discovery. Besides this, stem cells require long-term preservation solutions to ensure viability and functionality upon revival. Cell freezing media, particularly those containing cryoprotective agents like dimethyl sulfoxide (DMSO), are essential for maintaining the stem cells' integrity during the freezing and thawing. In addition to this, the increasing focus on regenerative medicine and therapies leading to a surge in stem cell research is supporting the market growth. Furthermore, the growing utilization of cell freezing media in personalized medicine, as it involves using a patient's cells for treatment, creating a positive outlook for the market growth.
Breakup by End Use:
- Pharmaceutical and Biotechnological Companies
- Research and Academic Institutes
Pharmaceutical and biotechnological companies dominate the market
The report has provided a detailed breakup and analysis of the market based on the end use. This includes pharmaceutical and biotechnological companies, research and academic institutes, and others. According to the report, pharmaceutical and biotechnological companies represented the largest segment.
Pharmaceutical and biotechnological companies hold the largest share of cell freezing media, as these industries are the primary hubs for research and development (R&D) activities, where cell-based assays, drug discovery, and biotechnological innovations are routine. In line with this, cell freezing media are indispensable in pharmaceutical research for ensuring that cells used in various stages of drug development maintain their integrity. Additionally, the cells used in drug discovery involving high-throughput screening, toxicology tests, and other cell-based assays need to be consistent in quality across different phases and locations, necessitating the use of specialized cell freezing media. Besides this, the increasing utilization of cell freezing media in biotechnological applications such as gene therapy, monoclonal antibody production, and recombinant protein synthesis is supporting the market growth. Additionally, the growing stringent regulatory guidelines concerning the quality and standardization of biological materials used in research and therapeutic applications, leading to the adoption of high-quality cell freezing media that can help companies comply with these regulations by providing a reliable method for cell preservation, is favoring the market growth.
Breakup by Region:
- North America
- United Kingdom
- Asia Pacific
- South Korea
- Latin America
North America exhibits a clear dominance, accounting for the largest cell freezing media market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America is dominating the cell-freezing media market due to the strong presence of leading pharmaceutical and biotechnological companies in this region. In line with this, North America is a hub for innovation in life sciences, and the concentration of research institutions, universities, and tech companies is further fueling the demand for high-quality cell-freezing media. Besides this, the high level of investment in healthcare and medical research by public and private sectors in North America, allocating substantial funds to scientific investigations, including those requiring cell preservation, is supporting the market growth. Moreover, the growing regulatory support by bodies like the U.S. Food and Drug Administration (FDA) introducing stringent guidelines for cellular research and pushing the use of high-standard cell freezing media to ensure the reliability and reproducibility of scientific results is propelling the market growth. Additionally, the region has a well-established distribution network for scientific and laboratory supplies, making it easier for end-users to access premium cell-freezing media.
The leading companies in the cell freezing media market are investing heavily in research and development (R&D) to develop new formulations that offer better cell viability and longer shelf-life, aiming to cater to the specialized needs of different cell types and research applications. Moreover, some companies are acquiring smaller firms with specialized technologies or market access to expand their product portfolio and geographical reach. Besides this, companies are also entering into strategic collaborations with research institutions, biotechnology firms, and pharmaceutical companies to facilitate knowledge exchange, co-development of products, and entry into new markets. Additionally, the key companies are focusing on meeting or exceeding these standards owing to the stringent regulations governing the quality and safety of cell freezing media. In addition to this, the key players are also investing in customer education through seminars, webinars, and published content. The objective is to educate end-users on the best practices in cell preservation and the advantages of using high-quality cell freezing media. Apart from this, some companies are researching and developing more sustainable alternatives to traditional cell-freezing media components without compromising effectiveness. Furthermore, the key firms are offering custom formulation services, which is particularly important for researchers dealing with unique cell types or specific experimental conditions.
The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:
- BioLifeSolutions Inc
- BPS Bioscience, Inc.
- Capricorn Scientific
- Cell Applications Inc.
- Cell Systems (AnaBios Corporation)
- HiMedia Laboratories
- Merck KGaA
- Sartorius AG
- STEMCELL Technologies
- Thermo Fisher Scientific Inc.
Cell Freezing Media Market Report Scope:
|Base Year of the Analysis
| Historical Period
|Scope of the Report
||Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment:
- End Use
||DMSO, Glycerol, Others
||Stem Cell Lines, Cancer Cell Lines, Others
|End Uses Covered
||Pharmaceutical and Biotechnological Companies, Research and Academic Institutes, Others
||Asia Pacific, Europe, North America, Latin America, Middle East and Africa
||United States, Canada, Germany, France, United Kingdom, Italy, Spain, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
||AMSBIO, BioLifeSolutions Inc, Bio-Techne, BPS Bioscience, Inc., Capricorn Scientific, Cell Applications Inc., Cell Systems (AnaBios Corporation), HiMedia Laboratories, Merck KGaA, Sartorius AG, STEMCELL Technologies, Thermo Fisher Scientific Inc., etc.
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
Key Questions Answered in This Report:
- How has the global cell freezing media market performed so far, and how will it perform in the coming years?
- What are the drivers, restraints, and opportunities in the global cell freezing media market?
- What is the impact of each driver, restraint, and opportunity on the global cell freezing media market?
- What are the key regional markets?
- Which countries represent the most attractive cell freezing media market?
- What is the breakup of the market based on the product?
- Which is the most attractive product in the cell freezing media market?
- What is the breakup of the market based on the application?
- Which is the most attractive application in the cell freezing media market?
- What is the breakup of the market based on the end use?
- Which is the most attractive end use in the cell freezing media market?
- What is the competitive structure of the global cell freezing media market?
- Who are the key players/companies in the global cell freezing media market?
Key Benefits for Stakeholders:
- IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the cell freezing media market from 2017-2028.
- The research report provides the latest information on the market drivers, challenges, and opportunities in the global cell freezing media market.
- The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
- Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the cell freezing media industry and its attractiveness.
- Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.